Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria

Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β- lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β- lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.

Saved in:
Bibliographic Details
Main Authors: Yusuf,I., Arzai,A.H., Haruna,M., Sharif,A.A., Getso,M.I.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Microbiologia 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822014000300005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1517-83822014000300005
record_format ojs
spelling oai:scielo:S1517-838220140003000052014-11-04Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, NigeriaYusuf,I.Arzai,A.H.Haruna,M.Sharif,A.A.Getso,M.I. AmpC β-lactamases extended spectrum β-lactamases coexistence prevalence Gram negative bacteria Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β- lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β- lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.info:eu-repo/semantics/openAccessSociedade Brasileira de MicrobiologiaBrazilian Journal of Microbiology v.45 n.3 20142014-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822014000300005en10.1590/S1517-83822014000300005
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Yusuf,I.
Arzai,A.H.
Haruna,M.
Sharif,A.A.
Getso,M.I.
spellingShingle Yusuf,I.
Arzai,A.H.
Haruna,M.
Sharif,A.A.
Getso,M.I.
Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
author_facet Yusuf,I.
Arzai,A.H.
Haruna,M.
Sharif,A.A.
Getso,M.I.
author_sort Yusuf,I.
title Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
title_short Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
title_full Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
title_fullStr Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
title_full_unstemmed Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
title_sort detection of multi drug resistant bacteria in major hospitals in kano, north-west, nigeria
description Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β- lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates (> 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β- lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.
publisher Sociedade Brasileira de Microbiologia
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822014000300005
work_keys_str_mv AT yusufi detectionofmultidrugresistantbacteriainmajorhospitalsinkanonorthwestnigeria
AT arzaiah detectionofmultidrugresistantbacteriainmajorhospitalsinkanonorthwestnigeria
AT harunam detectionofmultidrugresistantbacteriainmajorhospitalsinkanonorthwestnigeria
AT sharifaa detectionofmultidrugresistantbacteriainmajorhospitalsinkanonorthwestnigeria
AT getsomi detectionofmultidrugresistantbacteriainmajorhospitalsinkanonorthwestnigeria
_version_ 1756425044002603008